Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by askretkaon May 06, 2021 11:57pm

350 Views

Post# 33150044

Pancreatic data should be intresting

And how its received. I mean pancreatic cancer 5 year survival are the worst and any increase in survival should be important? Aware 1 data was good, Car-T mouse data backed up what they were seeing in Aware 1 early results and now Pancreatic data looks interesting. I'm putting this as basic as I can. The stock price confuses me but I've seen this all before. I'm still very very Bullish on the stock. Cheers!

<< Previous

Bullboard Posts

Next >>

Boeing workers end strike, return to work